Difference between revisions of "Sodium tetradecyl sulfate"

From Self-sufficiency
Jump to: navigation, search
m (Stub sorting and placement of stub template(s))
 
m (1 revision)
 
(No difference)

Latest revision as of 08:43, 20 September 2010

Sodium tetradecyl sulfate
File:Tetradecylsulfate.png
Systematic (IUPAC) name
Sodium tetradecylsulfate
Clinical data
Routes of
administration
Intravenous injection
Legal status
Legal status
  • Prescription only medicine
Identifiers
ATC code C05BB04 (WHO)
PubChem CID 14492
Chemical data
Formula C14H29NaO4S
Molar mass 316.43243 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Sodium tetradecyl sulfate (STS) is a sclerosant drug. It is commonly used in the treatment of varicose and spider veins of the leg, during the procedure of sclerotherapy. Being a detergent-based chemical, its action is on the lipid molecules in the cells of the vein wall, causing destruction of the internal lining of the vein and eventual sclerosis of the vein. It is used in concentrations ranging from 0.1% to 3% for this purpose. In the UK, Ireland, Italy, Australia, New Zealand and South Africa, it is sold under the trade-name Fibro-Vein in concentrations of 0.2%, 0.5%, 1.0%, and 3%.[1]

As of 30th October, 2009, it has been claimed that it can also stop snoring when injected into the roof of the mouth by hardening the soft tissues which vibrate. [2]



References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />



  1. Fibro-Vein history and details
  2. Times of India article